Phase I dose-escalation study of the pan-PI3 K inhibitor copanlisib in children and adolescents with relapsed/refractory solid tumors. (October 2022)
- Record Type:
- Journal Article
- Title:
- Phase I dose-escalation study of the pan-PI3 K inhibitor copanlisib in children and adolescents with relapsed/refractory solid tumors. (October 2022)
- Main Title:
- Phase I dose-escalation study of the pan-PI3 K inhibitor copanlisib in children and adolescents with relapsed/refractory solid tumors
- Authors:
- Macy, M.
Cash, T.
Pinto, N.
Pressey, J.G.
Szalontay, L.
Furman, W.L.
Bukowinski, A.
Foster, J.H.
Friedman, G.K.
HaDuong, J.
Fox, E.
Weigel, B.J.
Grevel, J.
Huang, F.
Phelps, C.
Childs, B.H.
Chung, J.
Chaturvedi, S.
Schulz, A.
DuBois, S.G. - Abstract:
- Is Part Of:
- European journal of cancer. Volume 174(2022)Supplement 1
- Journal:
- European journal of cancer
- Issue:
- Volume 174(2022)Supplement 1
- Issue Display:
- Volume 174, Issue 1 (2022)
- Year:
- 2022
- Volume:
- 174
- Issue:
- 1
- Issue Sort Value:
- 2022-0174-0001-0000
- Page Start:
- S28
- Page End:
- S29
- Publication Date:
- 2022-10
- Subjects:
- Cancer -- Periodicals
Neoplasms -- Periodicals
Cancer -- Périodiques
Cancer
Tumors
Electronic journals
Periodicals
Electronic journals
616.994 - Journal URLs:
- http://www.sciencedirect.com/science/journal/09598049 ↗
http://rzblx1.uni-regensburg.de/ezeit/warpto.phtml?colors=7&jour_id=2879 ↗
http://www.clinicalkey.com/dura/browse/journalIssue/09598049 ↗
http://www.clinicalkey.com.au/dura/browse/journalIssue/09598049 ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1016/S0959-8049(22)00878-4 ↗
- Languages:
- English
- ISSNs:
- 0959-8049
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3829.725100
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 24177.xml